Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: Are they related?

Journal of Neurology

Volumn 260, Issue 7, 2013, Pages 1752-1756

  Berganzo, Koldo ^a,b   Díez Arrola, Begoña ^c   Tijero, Beatriz ^a,b   Somme, Johanne ^d   Lezcano, Elena ^a,b   Llorens, Verónica ^a   Ugarriza, Iratxe ^a,b   Ciordia, Roberto ^a,b   Gomez Esteban J C ^a,b   Zarranz, Juan J ^a,b  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c Biscaye Parkinson's Disease Society   (Spain)

^d HOSPITAL TXAGORRITXU   (Spain)

Author keywords

24 h ambulatory blood pressure monitoring (ABPM); Autonomic disorders; Dopaminergic treatment; Nocturnal hypertension; Parkinson disease

Indexed keywords

ANTIHYPERTENSIVE AGENT; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; LISURIDE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DYSAUTONOMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NIGHT; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUSTAINED DRUG RELEASE; SYSTOLIC BLOOD PRESSURE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PARKINSON DISEASE; PRIMARY DYSAUTONOMIAS;

EID: 84880282905     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6859-5     Document Type: Article

References (19)

1. Kaufmann H, Goldstein DS (2007) Autonomic dysfunction in Parkinson's disease. Handb Clin Neurol 83:343-363
2. Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42(2):136-142
3. Jones CD, Loehr L, Franceschini N, Rosamond WD, Chang PP, Shahar E et al (2012) Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study. Hypertension 59(5):913-918
4. Schmidt C, Berg D, Prieur S, Junghanns S, Schweitzer K, Globas C et al (2009) Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord 24(14):2136-2142
5. Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L et al (2011) Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 57(6):1094-1100
6. Becker C, Jick SS, Meier CR (2008) Use of antihypertensives and the risk of Parkinson disease. Neurology 70(16 Pt 2):1438-1444
7. Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernandez del Rey R et al (2007) Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 25(5):977-984
8. Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson's disease and multiple system atrophy. J Hypertens 16(10):1433-1441
9. Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K et al (2011) PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Intern Med 50(22):2775-2781
10. Wilcox CS, Aminoff MJ, Slater JD (1977) Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med 53(4):321-328
11. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G (1987) Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5(1):93-98
12. Sommer S, Aral-Becher B, Jost W (2011) Nondipping in Parkinson's disease. Parkinson's disease 2011:897586
13. Maule S, Papotti G, Naso D, Magnino C, Testa E, Veglio F (2007) Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 7(1):63-70
14. Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM (2011) Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17(10):724-729
15. Suzuki M, Urashima M, Oka H, Hashimoto M, Taira K (2007) Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease. NeuroReport 18(17):1867-1870
16. Berganzo K, Tijero B, Somme JH, Llorens V, Sanchez-Manso JC, Low D et al (2012) SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord 18(1):45-48
17. Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord Off J Mov Dis Soc 22(7):1004-1008
18. Deuschl G, Schade-Brittinger C, Krack P et al (2006) A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355:896-908
19. Goldstein DS, Eldadah BA, Holmes C et al (2005) Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 46:1333-1339